PGNY

Progyny, Inc.

$36.43

1.34%
SectorHealthcareIndustryHealthcare PlansCountryUnited States

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc.

Source: Yahoo Finance
AI summary

Price & performance

1M+32.9%
3M+9.6%
YTD+33.5%
1Y+82.0%
52-week range—
Beta0.43
Full chart and returns against a benchmark

Q-Score

65/ 100

Quality against peers; 50 is the peer median.

Growth61
Risk55
Performance51
Valuation56
Profitability73
Leverage86
Sentiment62
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$1.3B+10.4%
Net income$58.5M+7.7%
Net margin4.5%-0.1 pts
Historical fundamentals

Revenue exposure

Regions, segments, customers and suppliers

Valuation

PGNYIndustryP/E29.4817.87P/S2.000.47EV/EBITDA19.3711.92P/B6.482.31PEG0.480.32
Dividend yield0.00%
Every valuation metric

Earnings

Nov 4next report
EPS estimate$0.51
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate